Both in Biotechnology
Precision BioSciences vs Protalix BioTherapeutics
Over the past year DTIL returned −5.3% and PLX returned +9.2%; their daily moves had a correlation of 0.13.
DTIL −5.3% PLX +9.2%Growth of $1, one year, split-adjusted
| Metric | DTIL | PLX |
|---|---|---|
| Price | $6.97 | $2.61 |
| Market cap | $192.4M | $210.3M |
| Today | +0.29% | +1.95% |
| 1 month | +10.5% | −3.7% |
| 6 months | −6.4% | +33.2% |
| Year to date | +67.5% | +45.0% |
| 1 year | −14.6% | +10.1% |
| Revenue growth (YoY) | — | +27.1% |
| Gross margin | — | 61.0% |
| Net margin | — | 19.0% |
| P/E (TTM) | — | 11.1× |
| Price / sales | — | 2.6× |
| Net cash | $65.1M | $40.7M |
| Dividend yield | — | — |
| Volatility (60d) | 62.8% | 44.8% |
| Short % of float | 9.1% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).